Eureka AIR delivers breakthrough ideas for toughest innovation challenges, trusted by R&D personnel around the world.

Sterilizing liquid for quick inactivating AIDS sex desease virus and sperm and its preparing method

A technology of AIDS virus and bactericidal solution, which is applied in the field of medicines and disinfection products, can solve problems in the experimental stage, achieve the effects of enhancing sensitivity and vitality, improving vaginal dryness, and promoting repair and healing

Active Publication Date: 2007-01-10
兰州和盛堂制药股份有限公司
View PDF3 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

New drugs are being developed to kill HIV and STD pathogens and completely prevent AIDS and STD infections, but most of them are in the experimental stage

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0039] Embodiment 1 prepares sterilizing liquid

[0040] (1) According to the formula description of each experimental scheme in Table 1, get the raw materials of corresponding weight respectively, mix them, make mixture:

[0041] raw material

[0042] (2) According to the formula of each experimental scheme in Table 2, take the raw materials of corresponding weight parts respectively, join in the mixture prepared in step (1), reconcile and stir into a transparent hydrogel:

[0043] raw material

[0044] (3) The filling machine divides into finished products.

Embodiment 2

[0045] The bactericidal effect experiment of embodiment 2 bactericidal liquid

[0046] 1. Experimental materials

[0047] Sample: the sterilizing solution prepared in Example 1, light yellow transparent liquid, stored at room temperature.

[0048] Test strains: Leptospira jaundice-hemorrhagic type 56601 and Leptospira typhoid type 56609 were used in the spirochete killing test; Neisseria gonorrhoeae 29106 was used in the gonorrhea killing test.

[0049] 2. Neutralizer test:

[0050] 2.1 Inspection basis: refer to Section 2.4 of the first volume of the "Technical Specifications for Disinfection" issued by the Ministry of Health.

[0051] 2.2 The neutralizer identification test adopts the suspension quantitative method, the action time of the bactericidal liquid and the test strain is 1 minute, and the neutralization time is 10 minutes. respectively at 37°C CO 2 Neisseria gonorrhoeae were cultured in an incubator and Leptospira were cultured in a 28°C incubator. The test wa...

Embodiment 3

[0066] Embodiment 3 sterilization liquid is to the killing effect experiment of HIV

[0067] 1. Test basis: "Virus inactivation test" in paragraph 2.1.1.10 of "Technical Specifications for Disinfection" (2002 edition).

[0068] 2. Experimental materials:

[0069] 2.1 Sample: the sterilizing solution prepared in Example 1, stored at room temperature.

[0070] 2.2 Human immunodeficiency virus: HIV~1 IIIB strain, passaged and cultured in MT4 cells.

[0071] 2.3 Cells: MT4 cells.

[0072] 2.4 Cell culture medium: RPMI 1640 culture medium containing 10 calf serum.

[0073] 2.5 Sterile deionized water.

[0074] 2.6 96-well cell culture plate.

[0075] 3. Experimental method:

[0076] Before the experiment, the sterilizing liquid samples were prepared into solutions of 1:10, 1:20, and 1:50 with sterile deionized water. Mix 0.9ml of samples with different concentrations (1:10, 1:20, 1:50) with 0.1ml of HIV-1 suspension, put them at room temperature for 1 minute, 5 minutes, and ...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The present invention provides a kind of sterilizing liquid capable of inactivating HIV, sex disease pathogens and sperm. The sterilizing liquid consists of chlorhexidine acetate 0.1-4.5 weight portions, polyoctyl phenol oxyethylene ether 0.01-6 weight portions, hyaluronic acid 0.01-8 weight portions, dihydroxymethyl glycolylurea 0.1-3 weight portions, aloe 25-60 weight portions, and pure water 30-70 weight portions. It may also contain nipagin M 0.1-2 weight portions, lactic acid 0.05-2 weight portions, glycerol 0.1-5 weight portions and hydroxyethyl cellulose 0.1-3 weight portions. The present invention also provides the preparation process of the sterilizing liquid.

Description

technical field [0001] The invention relates to the fields of medicines and disinfection products, in particular to a sterilizing solution capable of rapidly inactivating AIDS virus, various venereal pathogens and sperm and a preparation method thereof. Background technique [0002] At present, the incidence of various sexually transmitted diseases is increasing dramatically every year at an astonishing rate. By the end of 2002, the number of HIV-infected people in China had exceeded 1 million. China has entered a period of rapid AIDS growth, and it is estimated that by 2010, the number of HIV-infected people will reach 10 million. AIDS is threatening every one of us and every family. As an extremely urgent public health and social problem, the impact of AIDS has penetrated into all social strata, accompanied by a test of science, economy, morality, ethics and civilization, and a challenge to human life and Dignity challenge. The rapid development of AIDS clearly shows t...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): A01N65/00A01P3/00A61K36/00
Inventor 谢平
Owner 兰州和盛堂制药股份有限公司
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Eureka Blog
Learn More
PatSnap group products